These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37562710)

  • 1. Motor progression phenotypes in early-stage Parkinson's Disease: A clinical prediction model and the role of glymphatic system imaging biomarkers.
    He P; Gao Y; Shi L; Li Y; Jiang S; Tie Z; Qiu Y; Ma G; Zhang Y; Nie K; Wang L
    Neurosci Lett; 2023 Sep; 814():137435. PubMed ID: 37562710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroimaging uncovers distinct relationships of glymphatic dysfunction and motor symptoms in Parkinson's disease.
    Qin Y; He R; Chen J; Zhou X; Zhou X; Liu Z; Xu Q; Guo JF; Yan XX; Jiang N; Liao W; Taoka T; Wang D; Tang B
    J Neurol; 2023 May; 270(5):2649-2658. PubMed ID: 36856846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Predictive Nomogram for Possible REM Sleep Behavior Disorders.
    Lai H; Li XY; Hu J; Li W; Xu F; Zhu J; He R; Weng H; Chen L; Yu J; Li X; Song Y; Wang X; Wang Z; Li W; Kang R; Li Y; Xu J; Deng Y; Ye Q; Wang C
    Front Neurol; 2022; 13():903721. PubMed ID: 35847229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease progression subtypes of Parkinson's disease based on milestone events.
    Chen S; Wang MY; Shao JY; Yang HQ; Zhang HJ; Zhang JW
    J Neurol; 2024 Oct; 271(10):6791-6800. PubMed ID: 39187742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perivascular space in Parkinson's disease: Association with CSF amyloid/tau and cognitive decline.
    Chen H; Wan H; Zhang M; Wardlaw JM; Feng T; Wang Y
    Parkinsonism Relat Disord; 2022 Feb; 95():70-76. PubMed ID: 35051895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between body mass index and glymphatic function using diffusion tensor image-along the perivascular space (DTI-ALPS) in patients with Parkinson's disease.
    Tian S; Hong H; Luo X; Zeng Q; Huang P; Zhang M
    Quant Imaging Med Surg; 2024 Mar; 14(3):2296-2308. PubMed ID: 38545038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association of the Glymphatic Function with Parkinson's Disease Symptoms: Neuroimaging Evidence from Longitudinal and Cross-Sectional Studies.
    He P; Shi L; Li Y; Duan Q; Qiu Y; Feng S; Gao Y; Luo Y; Ma G; Zhang Y; Wang L; Nie K
    Ann Neurol; 2023 Oct; 94(4):672-683. PubMed ID: 37377170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion Tensor Imaging Analysis Along the Perivascular Space Index in Primary Parkinson's Disease Patients With and Without Freezing of Gait.
    Ruan X; Huang X; Li Y; Li E; Li M; Wei X
    Neuroscience; 2022 Dec; 506():51-57. PubMed ID: 36341724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-predictor modeling for predicting early Parkinson's disease and non-motor symptoms progression.
    Dou K; Ma J; Zhang X; Shi W; Tao M; Xie A
    Front Aging Neurosci; 2022; 14():977985. PubMed ID: 36092799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of Glymphatic Function with Cognitive Impairment, Sleep Disorders, Anxiety and Depression in Patients with Parkinson's Disease.
    Gui Q; Meng J; Shen M; Feng H; Dong X; Xu D; Zhu W; Cheng Q; Wang L; Wu G; Lu Y
    Neuropsychiatr Dis Treat; 2024; 20():1809-1821. PubMed ID: 39346025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram for Early Prediction of Parkinson's Disease Based on microRNA Profiles and Clinical Variables.
    Hou X; Wong G
    J Parkinsons Dis; 2023; 13(4):473-484. PubMed ID: 37212072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Motor progression trajectories and risk of mild cognitive impairment in Parkinson's disease: A latent class trajectory model from PPMI cohort.
    Chen X; He C; Ma J; Yang R; Qi Q; Gao Z; Du T; Zhang P; Li Y; Cai M; Zhang Y
    CNS Neurosci Ther; 2024 Aug; 30(8):e14918. PubMed ID: 39129413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion along perivascular spaces provides evidence interlinking compromised glymphatic function with aging in Parkinson's disease.
    Cai X; Chen Z; He C; Zhang P; Nie K; Qiu Y; Wang L; Wang L; Jing P; Zhang Y
    CNS Neurosci Ther; 2023 Jan; 29(1):111-121. PubMed ID: 36184792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion along perivascular spaces as marker for impairment of glymphatic system in Parkinson's disease.
    Shen T; Yue Y; Ba F; He T; Tang X; Hu X; Pu J; Huang C; Lv W; Zhang B; Lai HY
    NPJ Parkinsons Dis; 2022 Dec; 8(1):174. PubMed ID: 36543809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations among Cognitive Functions, Plasma DNA, and Diffusion Tensor Image along the Perivascular Space (DTI-ALPS) in Patients with Parkinson's Disease.
    Chen HL; Chen PC; Lu CH; Tsai NW; Yu CC; Chou KH; Lai YR; Taoka T; Lin WC
    Oxid Med Cell Longev; 2021; 2021():4034509. PubMed ID: 33680283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved nomogram including elastography for the prediction of non-sentinel lymph node metastasis in breast cancer patients with 1 or 2 sentinel lymph node metastases.
    Duan H; Zhang J; Zhang G; Zhu X; Wang W
    Front Oncol; 2023; 13():1196592. PubMed ID: 37342193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease.
    Zeighami Y; Fereshtehnejad SM; Dadar M; Collins DL; Postuma RB; Dagher A
    Neuroimage Clin; 2019; 24():101986. PubMed ID: 31514113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study.
    Nalls MA; McLean CY; Rick J; Eberly S; Hutten SJ; Gwinn K; Sutherland M; Martinez M; Heutink P; Williams NM; Hardy J; Gasser T; Brice A; Price TR; Nicolas A; Keller MF; Molony C; Gibbs JR; Chen-Plotkin A; Suh E; Letson C; Fiandaca MS; Mapstone M; Federoff HJ; Noyce AJ; Morris H; Van Deerlin VM; Weintraub D; Zabetian C; Hernandez DG; Lesage S; Mullins M; Conley ED; Northover CA; Frasier M; Marek K; Day-Williams AG; Stone DJ; Ioannidis JP; Singleton AB;
    Lancet Neurol; 2015 Oct; 14(10):1002-9. PubMed ID: 26271532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrative Nomogram for Identifying Early-Stage Parkinson's Disease Using Non-motor Symptoms and White Matter-Based Radiomics Biomarkers From Whole-Brain MRI.
    Shu Z; Pang P; Wu X; Cui S; Xu Y; Zhang M
    Front Aging Neurosci; 2020; 12():548616. PubMed ID: 33390927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.